SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-057258
Filing Date
2023-05-08
Accepted
2023-05-08 17:16:11
Documents
2
Period of Report
2023-05-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2314936-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2314936-1_3seq1.xml 3 1563
2 EXHIBIT 24 tm2314936d1_ex24.htm EX-24 9575
  Complete submission text file 0001104659-23-057258.txt   12497
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 267-370-5219
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
Gruia Gabriela (Reporting) CIK: 0001860326 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39069 | Film No.: 23898913